-
1
-
-
46349098998
-
Merck index
-
Maryadele JO, editor, 13th ed
-
Maryadele JO, editor. Merck index. 13th ed. NJ (USA): Merck Research Lab; 2001. p. 868.
-
(2001)
NJ (USA): Merck Research Lab
, pp. 868
-
-
-
2
-
-
0344628593
-
An HPLC method for the determination of atorvastatin and its impurities in bulk drug and tablets
-
Erturk S, Sevinc AE, Ersoy L, Ficicioglu S. An HPLC method for the determination of atorvastatin and its impurities in bulk drug and tablets. J Pharm Biomed Anal 2003;33:1017-23.
-
(2003)
J Pharm Biomed Anal
, vol.33
, pp. 1017-1023
-
-
Erturk, S.1
Sevinc, A.E.2
Ersoy, L.3
Ficicioglu, S.4
-
3
-
-
46349094721
-
Merck index
-
Maryadele JO, editor, 13th ed
-
Maryadele JO, editor. Merck index. 13th ed. NJ (USA): Merck Research Lab; 2001. p. 4005.
-
(2001)
NJ (USA): Merck Research Lab
, pp. 4005
-
-
-
5
-
-
19444387953
-
Spectrophotometric and liquid chromatographic determination of fenofibrate and vinpocetine and their hydrolysis products
-
El-Gindy A, Emara S, Mesbah MK, Hadad GM. Spectrophotometric and liquid chromatographic determination of fenofibrate and vinpocetine and their hydrolysis products. Farmaco 2005;60:425-38.
-
(2005)
Farmaco
, vol.60
, pp. 425-438
-
-
El-Gindy, A.1
Emara, S.2
Mesbah, M.K.3
Hadad, G.M.4
-
6
-
-
0031766228
-
High-performance liquid chromatographic method for the determination of fenofibric acid and reduced fenofibric acid in human blood, plasma and urine
-
Abe S, Ono K, Mogi M, Hayashi T. High-performance liquid chromatographic method for the determination of fenofibric acid and reduced fenofibric acid in human blood, plasma and urine. Yakugaku Zasshi 1998;118:447-55.
-
(1998)
Yakugaku Zasshi
, vol.118
, pp. 447-455
-
-
Abe, S.1
Ono, K.2
Mogi, M.3
Hayashi, T.4
-
7
-
-
0030582748
-
-
Masnatta LD, Cuniberti LA, Rey RH, Werba JP. Determination of bezafibrate, ciprofibrate and fenofibric acid in human plasma by high-performance liquid chromatography.J Chrom Biomed Appl 1996;687:437-42.
-
Masnatta LD, Cuniberti LA, Rey RH, Werba JP. Determination of bezafibrate, ciprofibrate and fenofibric acid in human plasma by high-performance liquid chromatography.J Chrom Biomed Appl 1996;687:437-42.
-
-
-
-
8
-
-
0031768869
-
Fenofibrate raw materials: HPLC methods for assay and purity and an NMR method for purity
-
Lacroix PM, Dawson BA, Sears RW, Black DB, Cyr TD, Ethier JC. Fenofibrate raw materials: HPLC methods for assay and purity and an NMR method for purity. J Pharm Biomed Anal 1998;18:383-402.
-
(1998)
J Pharm Biomed Anal
, vol.18
, pp. 383-402
-
-
Lacroix, P.M.1
Dawson, B.A.2
Sears, R.W.3
Black, D.B.4
Cyr, T.D.5
Ethier, J.C.6
-
9
-
-
0034625564
-
Determination of fenofibric acid in human plasma using automated solid-phase extraction coupled to liquid chromatography
-
Streel B, Hubert P, Ceccato A. Determination of fenofibric acid in human plasma using automated solid-phase extraction coupled to liquid chromatography. J Chromatogr Biomed Sci Appl 2000;742:391-400.
-
(2000)
J Chromatogr Biomed Sci Appl
, vol.742
, pp. 391-400
-
-
Streel, B.1
Hubert, P.2
Ceccato, A.3
-
10
-
-
0035145399
-
Rapid and simple method for detection of fenofibric acid in human serum by high-performance liquid chromatography
-
Lossner A, Banditt P, Troger U. Rapid and simple method for detection of fenofibric acid in human serum by high-performance liquid chromatography. Pharmazie 2001;56:50-1.
-
(2001)
Pharmazie
, vol.56
, pp. 50-51
-
-
Lossner, A.1
Banditt, P.2
Troger, U.3
-
11
-
-
18544410629
-
Antilipemic agents in combined therapy
-
Mark L, Csaszar A. Antilipemic agents in combined therapy. Orv Hetil 2002;143:1973-8.
-
(2002)
Orv Hetil
, vol.143
, pp. 1973-1978
-
-
Mark, L.1
Csaszar, A.2
-
12
-
-
46349094995
-
-
International conference on harmonization, Guidance for industry. In: Q2B Validation on Analytical Procedures: Methodology, 1996. p. 2.
-
International conference on harmonization, Guidance for industry. In: Q2B Validation on Analytical Procedures: Methodology, 1996. p. 2.
-
-
-
|